- Home
- FTK vs RPTX Comparison
FTK vs RPTX Comparison
Compare FTK & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTK
- RPTX
- Stock Information
- Founded
- FTK 1985
- RPTX 2016
- Country
- FTK United States
- RPTX Canada
- Employees
- FTK N/A
- RPTX N/A
- Industry
- FTK Major Chemicals
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- FTK Industrials
- RPTX Health Care
- Exchange
- FTK Nasdaq
- RPTX Nasdaq
- Market Cap
- FTK 336.2M
- RPTX 69.2M
- IPO Year
- FTK N/A
- RPTX 2020
- Fundamental
- Price
- FTK $12.97
- RPTX $1.77
- Analyst Decision
- FTK Buy
- RPTX Strong Buy
- Analyst Count
- FTK 2
- RPTX 3
- Target Price
- FTK $12.00
- RPTX $4.50
- AVG Volume (30 Days)
- FTK 343.2K
- RPTX 96.2K
- Earning Date
- FTK 11-03-2025
- RPTX 11-06-2025
- Dividend Yield
- FTK N/A
- RPTX N/A
- EPS Growth
- FTK 82.12
- RPTX N/A
- EPS
- FTK 0.43
- RPTX N/A
- Revenue
- FTK $214,211,000.00
- RPTX $250,000.00
- Revenue This Year
- FTK $19.47
- RPTX N/A
- Revenue Next Year
- FTK $11.22
- RPTX N/A
- P/E Ratio
- FTK $29.81
- RPTX N/A
- Revenue Growth
- FTK 21.72
- RPTX N/A
- 52 Week Low
- FTK $4.55
- RPTX $0.89
- 52 Week High
- FTK $16.87
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- FTK 61.31
- RPTX 65.37
- Support Level
- FTK $10.95
- RPTX $1.66
- Resistance Level
- FTK $11.69
- RPTX $1.83
- Average True Range (ATR)
- FTK 0.56
- RPTX 0.07
- MACD
- FTK 0.15
- RPTX 0.00
- Stochastic Oscillator
- FTK 99.36
- RPTX 74.00
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.